Tasigna off label for parkinson's disease... - Cure Parkinson's

Cure Parkinson's

25,507 members26,822 posts

Tasigna off label for parkinson's disease. What happens when the smallest kid on the block gets run out of town. Time for a vote.

Isthistheone profile image
18 Replies

Hello People With Parkinson's (PWP). I started this post two weeks ago. It wasn't worth the effort so I deleted it. I was hurting at the tim, my levodopa tank was running on fumes. I reminded myself that if I couldn't be cured I would try to make it easier for the next person. I am in my 18th year battling this major league illness. I have always played the odds, and I know I'm winning. My neuro doesn't refer to my condition as Stage 4 or5, he simply calls it advanced Parkinson's. I also made a vow to never give up. PWP I know how difficult that can be. Life is still good, in fact it is very good. We have three children and six grandchildren. I would like to shake the person's hand who said "if I knew grandchildren were going to be this much fun, i would have had them first! " My wife has always been the prettiest girl in the room! Definitely need to tell her that more often. We celebrated our 50th wedding anniversary last week!!! Hey old man Parkinson's you didn't win that one did you? I'm betting you all have won many battles too! My son and I completed our MLB STADIUM TOUR in 2019. We visited every MLB ballpark and saw a game at each one. It took us 18 years and we logged 36,000 +/- miles to visit 31 ballparks to complete our journey. Some years we would do 2-3 ballparks, other years we didn't do any. There are 30 MLB ballparks, so how did we finish with 31? You MLB aficionados will figure it out. That's another one in your loss column old man Parkinson!! The Toronto Blue Jays don't play in a ballpark or a stadium, they play at the Rogers Centre. Figure that one out?!#$

I have severe dyskenesia at times that I cannot control. It happens with out warning. I've lost texts of 500 + words when it hits me. I will finish what I started. I will be completely honest, but I am opinionated. I mean no disrespect to anyone or any group or institution. I request the health unlocked admin personnel to not censor or take down any of my comments. I'm not an expert on what I am about to write. Criticize all you want. To all the dedicated researchers who are working tirelessly to put this disease in the rear view mirror, THANK YOU FOR ALL YOUR EFFORTS. To all the doctors and support staff, thank you for keeping us moving. PWP know how difficult it is for you to see our decline and not be able to slow it down or stop it. Finally to the amazing people that make it all happen --- our CARE GIVERS !! Most care givers are family members, but all of you are ANGELS from HEAVEN!! Most of us wouldn't be here without you and that's a fact!!

TASIGNA was approved by the FDA in 2010. It is a 2nd generation cancer drug for patients

diagnosed with Chronic Myloid Leukemia (CML), Gleevec was the first and was FDA pproved in 2001, after the shortest FDA review in history --- 2.5 months!! Both drugs were developed and marketed by Novartis, both are tyrosine kinase inhibitors-- more on that later. Before Gleevec came out a CML diagnosis was a death sentence. I will not get into statistics, but Gleevec more than tripled CML survival rates. TASIGNA was developed for CML patients who did not have a favorable response to Gleevec. Both of these medications are considered targeted therapy medications. In fact Gleevec was the first targeted therapy drug on the planet!! A targeted therapy medication mainly kills cancer cells. Chemo therapy destroys both healthy and cancerous cells.

In the 1950 - 60s most medical professionals were of the opinion that cancers were not of genetic origin. Two researchers at the University of Pennsylvania shared an interest in the human chromosome structure. Dr Peter Newell, MD and Dr Paul Hungerford, PhD, were the first to discover a shortened chromosome in blood samples from CML patients. They made their discovery in 1960. It would be 40 + years for medical technology to catch up and develop a drug to treat CML.

Tyrosine kinases are enzymes that act on proteins and give them directions at the cellular level. They tell many proteins when to start and when to stop their metabolic process. There is enough evidence that suggests TKIs ARE NOT TELLING certain proteins to shut down! So the "faucet " winds up in the on position! I never knew this until a few days ago, but some cancers leave their calling cards in the form of high amounts of tyrosine kinases observed at the cancer site. The oncology response has been to provide the sick patient with tyrosine kinase inhibitors!!!

ARE TYROSINE KINASES RESPONSIBLE???

I always believed that TASIGNA ( generic Nilotinib) could be a game changer for treating PD. This was based on my experience taking TASIGNA off label for PD. The following positive changes I consider the most noteworthy:

1. After only five days I was sleeping through the night.

2. I was mowing, my lawn in one day after 20 days of medication. I didn't have the strength, even back then (2017).

3. PWP are always "wound up ", PD puts all of your muscles in to a constant state of flex. Within the first two weeks I could feel my body limbering up. That PD stiffness was a memory.

4. I was consistently dosing every three hours beginning at 5 am, a daily total of eight times, 24/7. There were times when I was sleeping I would miss a dose, this was usually the 11 pm and the 2 am dosing times. Before TASIGNA there were times when I couldn't last 3 hours till my next dose. There were many times when I could skip my levodopa - I DIDN'T NEED IT!!! While on TASIGNA, I once went 15 hours between doses!!

5. When I started on TASIGNA, my dose was 300 mg levodopa every three hours. That's a total of 2400 mg daily. There were days when I took only 800 mg levodopa, one day I only took 500 mg!!

6. I lost my sense of smell many years ago. It came back!

For the past three years or so I haven't been as active surfing the net running down trials/studies. To be honest I became a little disillusioned by the FDA procedure for medication approval. Our biggest supporter (not mentioning names ) tried to muscle in on an active trial. JMO, so I'm leaving it there.

So is there some evidence that suggests TKIs may be helpful in our battle with PD?

MarionP thank you for what could be the best news that PWP have been patiently waiting for such a long time!

Must reads see MarionP, Jeffrey and park bear links

Written by
Isthistheone profile image
Isthistheone
To view profiles and participate in discussions please or .
Read more about...
18 Replies
MarionP profile image
MarionP

Not nilotinib. It doesn't get in, nor stay in, the brain enough to make a difference.

But look this paper over... Extremely exciting...extremely...very extremely. Quite extremely.

movementdisorders.onlinelib...

Boscoejean profile image
Boscoejean in reply to MarionP

so is this the clinical trial? inhibikase?

clinicaltrials.gov/ct2/show...

jeffreyn profile image
jeffreyn in reply to Boscoejean

That's it. It's a Phase 2 trial of IkT-148009.

park_bear profile image
park_bear in reply to jeffreyn

Company presentation here:

d1io3yog0oux5.cloudfront.ne...

park_bear profile image
park_bear in reply to park_bear

science.org/doi/10.1126/sci...

"IkT-148009, a brain-penetrant c-Abl inhibitor with a favorable toxicology profile, was analyzed for therapeutic potential in animal models of slowly progressive, α-synuclein–dependent PD. In mouse models of both inherited and sporadic PD, IkT-148009 suppressed c-Abl activation to baseline and substantially protected dopaminergic neurons from degeneration when administered therapeutically by once daily oral gavage beginning 4 weeks after disease initiation. Recovery of motor function in PD mice occurred within 8 weeks of initiating treatment concomitantly with a reduction in α-synuclein pathology in the mouse brain"

This is a valid study by researchers actually interested in treating Parkinson's - treatment is applied after development of actual Parkinson's (Versus the vast majority of studies out there that pretreat with the test compound before the development of any illness, just to publish something)

park_bear profile image
park_bear in reply to Boscoejean

Looks like study will involve a spinal tap to access cerebral spinal fluid. Note - among inclusion criteria:

"Receiving no anti-parkinsonian therapy"

Exclusion criteria:

"Past treatment with levodopa, dopaminergic agonists, monoamine oxidase-B inhibitors, or A2A antagonists for more than 28 days, or treatment with any of these medications within 28 days prior to screening"

Going to have a hard time filling this study.

Boscoejean profile image
Boscoejean in reply to park_bear

I kind of wondered about that when I was reading the details and I did think it sounded like they were ruling out almost everyone plus the idea of a spinal tap is rather off putting so how are they ever going to know if this would benefit the vast majority of individuals who might benefit and why are the criteria so narrow?

Ctime profile image
Ctime in reply to park_bear

I have had a spinal though for a study and it was a complete non issue for me. Less discomfort than some blood draws. I realize other people may have different experiences and there is risk of complication but I would not let the idea of a spinal dissuade anyone from a study, diagnostic or treatment. The treatment naïve is tough... but unfortunately more people are coming into this pipeline. They need to get the word out to neuro's that are outside of study centers

Isthistheone profile image
Isthistheone in reply to Ctime

NO SPINAL TAPS!! I had 3-4 back in the day. The doctors didn't want to perform them, too much risk. I have some nasty dyskenesia 24/7.NO TAPS FOR ME.

WinnieThePoo profile image
WinnieThePoo in reply to park_bear

Those criteria were identical for the biogen spark study I participated in and biogen had no problem recruiting for that.The ikt-148009 201 trial needs only half the number recruited for spark and has started dosing patients

Isthistheone profile image
Isthistheone in reply to MarionP

Thank you for your tremendous help. This is the best news PWP have seen.

Isthistheone profile image
Isthistheone in reply to MarionP

Marion, this study makes sense to me. Looking at the requirements I don't think I qualify (orthostatic hypotension) I'll ask my neurologist. ParkBear mentions you have to be free of anti PD meds and levodopa free has to be a mistake.

My first time on TASIGNA was 200 mg, 2nd time was 150 mg. First time was for 240 days. All improvements were observed in the first 90 days. My 2nd time on TASIGNA lasted 44 days. My GP observed an irregular heart beat on my monthly EKG. My cardiologist was not available for review. The Georgetown University doctor ordered me off Tasigna. My cardiologist upon his return said my extra heart beat wasn't a problem, Too little too late.

Isthistheone profile image
Isthistheone in reply to MarionP

Hi Marion, I could use some help. I remember reading amounts required to achieve results but can't find it. Question I have at what level would a TKI have to Pentwater to produce an effect? I know the science is not there yet. What explains my improvements while on TASIGNA, how did they come up with a number. What number would explain my very positive results? Maybe it's a lot less l

MarionP profile image
MarionP in reply to Isthistheone

Sorry, I have no idea how to answer that one.

Also, the article was not that favorable about Tasigna, it was talking about an animal study that noticed that Tasigna (nilotinib) did not stay in the mouse brain long enough because a of substance that transports it back out of the brain... again, in the rodent. So maybe it has better stability in the human brain, or at least yours (nothing personal). They identified I think 3 others of the related kinase inhibitors though and did not think they had the same vulnerability and that's the best part of the study, although yes there was some benefit in Tasigna...in your case. So that's about all I know really, what was in the study. You never know how much can generalize over from animal to humans, which is why of course they have to have human trials. Good news though for you and I'm glad of that.

Bolt_Upright profile image
Bolt_Upright

Nilotinib in Parkinson's disease: A systematic review and meta-analysis 2022 frontiersin.org/articles/10...

purple-0217 profile image
purple-0217

Wow!! Thank you for letting me into your life. For sharing your story. I am thrilled that you are doing well on this drug. I feel like there is hope.

kaypeeoh profile image
kaypeeoh

I think the drug for Chronic Myloid Leukemia was found to help those who coincidentally also had PD? I recall it bolstered the BBB. Because I don't have much symptoms I wondered if this might stop dopamine loss through the BBB. I asked the doc about it but didn't get an answer. Hopefully I can remember to bring it up at the next checkup.

Isthistheone profile image
Isthistheone in reply to kaypeeoh

Doubt it, but who knows. Repressing wasn't a hot topic back then.

You may also like...

Twist of fate: What happens when a top Parkinson's researcher gets the disease?

org/content/article/twist-fate-what-happens-when-top-parkinson-s-researcher-gets-disease

Interesting Gender Research Findings RE: Levodopa Absorption Rates

higher absorption of levodopa in patients treated with levodopa/benserazide versus...

Withdrawal when trying to reduce Levodopa

symptoms when tapering or stopping the treatment with Levodopa (L/C or Levodopa/Benzarazide).If you...

The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study

untreated patients who displayed a worsening of these parameters despite increased levodopa doses....

Light Therapy Clinical Trial

the efficacy of our proprietary phototherapy device to treat the symptoms of Parkinson's disease....